Tuberculosis News and Research

Latest Tuberculosis News and Research

Study reveals how tuberculosis bacteria form cords to resist antibiotics

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago. In a study published October 20 in the journal Cell, investigators report the biophysical mechanisms by which these cords form and demonstrate how several generations of dividing bacteria hang together to create these structures that enable resistance to antibiotics.

20 Oct 2023

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

The success and challenges of developing different tuberculosis (TB) vaccine types.

17 Oct 2023

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

A new study from the University of Pittsburgh Center for Vaccine Research published today in the Journal of Experimental Medicine describes a previously unappreciated role for a class of immune cells in the early stages of tuberculosis (TB) infection.

16 Oct 2023

New TB treatments tackle the disease without wrecking your microbiome

Researchers in a study published in The Lancet Microbe examined how various tuberculosis treatment regimens affect the respiratory microbiome. They found that certain treatments control tuberculosis effectively while minimally impacting the diversity and health of the respiratory microbiome.

15 Oct 2023

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.

14 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

Fighting tuberculosis: Breakthrough analysis reveals mixed strain infections

The drug-resistant genotypes in mixed strain infection (MSI) samples of Mycobacterium tuberculosis.

12 Oct 2023

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

Researchers examine the mechanisms responsible for the increased risk of neurocognitive impairment in HIV patients and explore potential treatments.

12 Oct 2023

New TB vaccination strategy could save hundreds of thousands of lives with HIV

Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.

10 Oct 2023

Epidemic: Bodies remember what was done to them

Global fears of overpopulation in the '60s and '70s helped fuel India's campaign to slow population growth.

10 Oct 2023

COVID-19's ripple effect: South African TB diagnostics take a hit

COVID-19 disrupts TB diagnostic services in South Africa's primary health clinics, highlighting the need for robust systems resilient to future pandemics.

8 Oct 2023

'Guard mechanism' discovered for protein that attacks microbes in infected cells

Researchers have identified a 'guard mechanism' for a protein which attacks microbes in infected cells, opening the possibility of new treatments for Toxoplasma, Chlamydia, Tuberculosis and even cancer.

5 Oct 2023

Researchers develop new way to boost immune cells' ability to fight TB

Tuberculosis is old - ancient even. The infectious bacterial disease that plagued Old Testament Israelites and took down pharaohs was eventually stunted by vaccinations, antibiotics, and public health measures like isolation, but it hasn't been cured yet.

27 Sep 2023

Tuberculosis News and Research

Latest Tuberculosis News and Research

Study reveals how tuberculosis bacteria form cords to resist antibiotics

Promising breakthroughs ignite hope for a novel and effective Tuberculosis vaccine

Study reveals previously unappreciated role for innate immune cells in early stages of TB infection

New TB treatments tackle the disease without wrecking your microbiome

Gates Foundation announces investments to advance mRNA vaccine research and manufacturing

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

Fighting tuberculosis: Breakthrough analysis reveals mixed strain infections

Unlocking hope: Promising treatments for cognitive impairment in HIV patients on the horizon

New TB vaccination strategy could save hundreds of thousands of lives with HIV

Epidemic: Bodies remember what was done to them

COVID-19's ripple effect: South African TB diagnostics take a hit

'Guard mechanism' discovered for protein that attacks microbes in infected cells

Researchers develop new way to boost immune cells' ability to fight TB

HMS researcher to lead $104 million effort to study bacteria and antibiotic resistance

New guideline with preventive care recommendations aims to promote health equity in Canada

TB cases in England increase by 7% in the first half of 2023

New UK funding will help tackle the world's most pressing health challenges

Global talks at UN to focus on pandemic preparedness, universal health coverage, and TB

Health workers warn loosening mask advice in hospitals would harm patients and providers

Can upper respiratory tract specimens be used to diagnose Tuberculosis?

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Tuberculosis News and Research

Latest Tuberculosis News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in